Methyldopa Waymade

Methyldopa, the active ingredient in Methyldopa Waymade, is an Alpha-2 adrenergic agonist presented as a tablet for oral use. It lowers blood pressure in adults with hypertension, including gestational hypertension.

GNH USA supplies Methyldopa Waymade as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methyldopa is used to manage conditions related to elevated blood pressure.

Hypertension: reduces systolic and diastolic pressure in adult patients. Gestational hypertension: controls blood pressure in pregnant women with hypertension. Essential hypertension: maintains target blood pressure levels in patients with primary hypertension.

Methyldopa may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or drowsiness - Dry mouth - Nausea or upset stomach - Constipation

Serious or Rare Side Effects: - Severe hypotension - Liver enzyme elevation or hepatitis - Hemolytic anemia - Stevens‑Johnson syndrome or severe skin reactions - Agranulocytosis or severe neutropenia - Lupus‑like syndrome

Before initiating therapy, clinicians should consider several safety measures.

Monitor blood pressure: adjust dose to avoid excessive hypotension. Assess liver function: periodic liver enzyme testing is advisable. Avoid abrupt discontinuation: taper the dose to prevent rebound hypertension. Use caution in cardiovascular disease: patients with coronary artery disease may be more sensitive. Pregnancy Category B: generally considered safe, but monitor maternal and fetal status. Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Methyldopa can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension. - Clonidine: additive hypotensive effect. - Other central alpha‑2 agonists: may cause excessive blood pressure lowering.

Moderate Interactions (Monitor Closely):\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive response. - Diuretics: increase risk of orthostatic hypotension. - Antidepressants (tricyclics, SSRIs): may enhance central effects. - Antidiabetic agents: blood pressure changes can affect glucose control. - Anesthetic agents: may potentiate hypotension during surgery.